Recital 2, Regulation (EU) 2022/2304

In forcesince 24 Nov 2022

Following the establishment of the European Union reference laboratory for Rift Valley fever, and in accordance with Article 93(2), point (a), of Regulation (EU) 2017/625, the Commission followed a public selection process for the designation of the European Union reference laboratory for Rift Valley fever.